CD163 and squamous cell carcinoma: In parallel, CD163—a marker of M2 macrophages involved in immunosuppression and tissue remodeling [28]—was detected in all three tissue types, with a moderate increase in squamous carcinoma (++) (Figure 4E), indicating a progressive activation of the stromal immune response.